338 related articles for article (PubMed ID: 23347441)
1. Systematic review of the incidence and prevalence of genital warts.
Patel H; Wagner M; Singhal P; Kothari S
BMC Infect Dis; 2013 Jan; 13():39. PubMed ID: 23347441
[TBL] [Abstract][Full Text] [Related]
2. Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study.
Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
BMJ Open; 2016 Mar; 6(3):e009914. PubMed ID: 26966057
[TBL] [Abstract][Full Text] [Related]
3. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
Vaccine; 2016 Sep; 34(39):4678-4683. PubMed ID: 27527815
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis.
Banura C; Mirembe FM; Orem J; Mbonye AK; Kasasa S; Mbidde EK
Infect Agent Cancer; 2013 Jul; 8(1):27. PubMed ID: 23842471
[TBL] [Abstract][Full Text] [Related]
5. Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada.
Kliewer EV; Demers AA; Elliott L; Lotocki R; Butler JR; Brisson M
Sex Transm Dis; 2009 Jun; 36(6):380-6. PubMed ID: 19556932
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of human papillomavirus on anogenital warts in Portugal - The HERCOLES study.
Azevedo J; Pista A; Lisboa C; Santo I; Azevedo L; Cunha MJ;
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1342-1348. PubMed ID: 28485812
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
Thöne K; Horn J; Mikolajczyk R
BMC Infect Dis; 2017 Aug; 17(1):564. PubMed ID: 28806926
[TBL] [Abstract][Full Text] [Related]
9. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
Steben M; Ouhoummane N; Rodier C; Sinyavskaya L; Brassard P
J Med Virol; 2018 Mar; 90(3):592-598. PubMed ID: 28980715
[TBL] [Abstract][Full Text] [Related]
10. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
Husein-ElAhmed H
Int J STD AIDS; 2020 Jun; 31(7):606-612. PubMed ID: 32438856
[TBL] [Abstract][Full Text] [Related]
11. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination.
Tyros G; Mastraftsi S; Gregoriou S; Nicolaidou E
Int J STD AIDS; 2021 Jan; 32(1):4-13. PubMed ID: 33167803
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
Thurgar E; Barton S; Karner C; Edwards SJ
Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study.
Chikandiwa A; Chimoyi L; Pisa PT; Chersich MF; Muller EE; Michelow P; Mayaud P; Delany-Moretlwe S
BMC Public Health; 2017 Jul; 17(Suppl 3):425. PubMed ID: 28832285
[TBL] [Abstract][Full Text] [Related]
14. Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
Shing JZ; Hull PC; Zhu Y; Gargano JW; Markowitz LE; Cleveland AA; Pemmaraju M; Park IU; Whitney E; Mitchel EF; Griffin MR
Papillomavirus Res; 2019 Jun; 7():141-149. PubMed ID: 30980966
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Cervico-vaginal High-risk HPV Types and Other Sexually Transmitted Pathogens in Anogenital Warts Patients.
Mortaki D; Tsitsopoulos E; Louizou E; Tsiambas E; Peschos D; Sioulas V; Galanos A; Tagka A; Gregoriou S; Stratigos A; Rigopoulos D; Nicolaidou E
Anticancer Res; 2020 Apr; 40(4):2219-2223. PubMed ID: 32234917
[TBL] [Abstract][Full Text] [Related]
16. High-grade Dysplasia in Anogenital Warts of HIV-Positive Men.
Kreuter A; Siorokos C; Oellig F; Silling S; Pfister H; Wieland U
JAMA Dermatol; 2016 Nov; 152(11):1225-1230. PubMed ID: 27463201
[TBL] [Abstract][Full Text] [Related]
17. Anogenital warts in Danish men who have sex with men.
Skaaby S; Kofoed K
Int J STD AIDS; 2011 Apr; 22(4):214-7. PubMed ID: 21515754
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa.
Chikandiwa A; Pisa PT; Muller EE; Tamalet C; Mayaud P; Chersich MF; Delany-Moretlwe S
Sex Transm Dis; 2019 May; 46(5):347-353. PubMed ID: 30985636
[TBL] [Abstract][Full Text] [Related]
19. Number of external anogenital warts is associated with the occurrence of abnormal cervical cytology.
Chayachinda C; Boriboonhirunsarn D; Thamkhantho M; Nuengton C; Chalermchockcharoenkit A
Asian Pac J Cancer Prev; 2014; 15(3):1177-80. PubMed ID: 24606437
[TBL] [Abstract][Full Text] [Related]
20. Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study.
Willows K; Bozat-Emre S; Righolt CH; Kliewer EV; Mahmud SM
Sex Transm Dis; 2018 Apr; 45(4):254-259. PubMed ID: 29465699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
